Global Erythropoietin Stimulating Agents Supply, Demand and Key Producers, 2023-2029

Page: 108

Published Date: 16 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

This report studies the global Erythropoietin Stimulating Agents demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Erythropoietin Stimulating Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Erythropoietin Stimulating Agents that contribute to its increasing demand across many markets.

The global Erythropoietin Stimulating Agents market size is expected to reach $ 6663.4 million by 2029, rising at a market growth of 1.2% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Erythropoietin Stimulating Agents total market, 2018-2029, (USD Million)
Global Erythropoietin Stimulating Agents total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Erythropoietin Stimulating Agents total market, key domestic companies and share, (USD Million)
Global Erythropoietin Stimulating Agents revenue by player and market share 2018-2023, (USD Million)
Global Erythropoietin Stimulating Agents total market by Type, CAGR, 2018-2029, (USD Million)
Global Erythropoietin Stimulating Agents total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Erythropoietin Stimulating Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson and Johnson and Teva Pharmaceutical Industries, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Erythropoietin Stimulating Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Erythropoietin Stimulating Agents Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Erythropoietin Stimulating Agents Market, Segmentation by Type
    Epoetin Alfa
    Epoetin Beta
    Darbepoetin Alfa
    Others

Global Erythropoietin Stimulating Agents Market, Segmentation by Application
    Hospitals
    Clinics
    Others

Companies Profiled:
    Pfizer
    Amgen
    BioSidus
    Biocon
    Celltrion
    Roche
    Intas Pharmaceuticals
    Johnson and Johnson
    Teva Pharmaceutical Industries
    Thermo Fisher Scientific

Key Questions Answered
1. How big is the global Erythropoietin Stimulating Agents market?
2. What is the demand of the global Erythropoietin Stimulating Agents market?
3. What is the year over year growth of the global Erythropoietin Stimulating Agents market?
4. What is the total value of the global Erythropoietin Stimulating Agents market?
5. Who are the major players in the global Erythropoietin Stimulating Agents market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Erythropoietin Stimulating Agents Introduction
    1.2 World Erythropoietin Stimulating Agents Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Erythropoietin Stimulating Agents Total Market by Region (by Headquarter Location)
        1.3.1 World Erythropoietin Stimulating Agents Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.3 China Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.4 Europe Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.5 Japan Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.6 South Korea Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.7 ASEAN Erythropoietin Stimulating Agents Market Size (2018-2029)
        1.3.8 India Erythropoietin Stimulating Agents Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Erythropoietin Stimulating Agents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Erythropoietin Stimulating Agents Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.2 World Erythropoietin Stimulating Agents Consumption Value by Region
        2.2.1 World Erythropoietin Stimulating Agents Consumption Value by Region (2018-2023)
        2.2.2 World Erythropoietin Stimulating Agents Consumption Value Forecast by Region (2024-2029)
    2.3 United States Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.4 China Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.5 Europe Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.6 Japan Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.7 South Korea Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.8 ASEAN Erythropoietin Stimulating Agents Consumption Value (2018-2029)
    2.9 India Erythropoietin Stimulating Agents Consumption Value (2018-2029)

3 World Erythropoietin Stimulating Agents Companies Competitive Analysis
    3.1 World Erythropoietin Stimulating Agents Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Erythropoietin Stimulating Agents Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Erythropoietin Stimulating Agents in 2022
        3.2.3 Global Concentration Ratios (CR8) for Erythropoietin Stimulating Agents in 2022
    3.3 Erythropoietin Stimulating Agents Company Evaluation Quadrant
    3.4 Erythropoietin Stimulating Agents Market: Overall Company Footprint Analysis
        3.4.1 Erythropoietin Stimulating Agents Market: Region Footprint
        3.4.2 Erythropoietin Stimulating Agents Market: Company Product Type Footprint
        3.4.3 Erythropoietin Stimulating Agents Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Erythropoietin Stimulating Agents Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Erythropoietin Stimulating Agents Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Erythropoietin Stimulating Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Erythropoietin Stimulating Agents Consumption Value Comparison
        4.2.1 United States VS China: Erythropoietin Stimulating Agents Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Erythropoietin Stimulating Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Erythropoietin Stimulating Agents Companies and Market Share, 2018-2023
        4.3.1 United States Based Erythropoietin Stimulating Agents Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023)
    4.4 China Based Companies Erythropoietin Stimulating Agents Revenue and Market Share, 2018-2023
        4.4.1 China Based Erythropoietin Stimulating Agents Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023)
    4.5 Rest of World Based Erythropoietin Stimulating Agents Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Erythropoietin Stimulating Agents Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Erythropoietin Stimulating Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Epoetin Alfa
        5.2.2 Epoetin Beta
        5.2.3 Darbepoetin Alfa
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Erythropoietin Stimulating Agents Market Size by Type (2018-2023)
        5.3.2 World Erythropoietin Stimulating Agents Market Size by Type (2024-2029)
        5.3.3 World Erythropoietin Stimulating Agents Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Erythropoietin Stimulating Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Erythropoietin Stimulating Agents Market Size by Application (2018-2023)
        6.3.2 World Erythropoietin Stimulating Agents Market Size by Application (2024-2029)
        6.3.3 World Erythropoietin Stimulating Agents Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Erythropoietin Stimulating Agents Product and Services
        7.1.4 Pfizer Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Amgen
        7.2.1 Amgen Details
        7.2.2 Amgen Major Business
        7.2.3 Amgen Erythropoietin Stimulating Agents Product and Services
        7.2.4 Amgen Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Amgen Recent Developments/Updates
        7.2.6 Amgen Competitive Strengths & Weaknesses
    7.3 BioSidus
        7.3.1 BioSidus Details
        7.3.2 BioSidus Major Business
        7.3.3 BioSidus Erythropoietin Stimulating Agents Product and Services
        7.3.4 BioSidus Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 BioSidus Recent Developments/Updates
        7.3.6 BioSidus Competitive Strengths & Weaknesses
    7.4 Biocon
        7.4.1 Biocon Details
        7.4.2 Biocon Major Business
        7.4.3 Biocon Erythropoietin Stimulating Agents Product and Services
        7.4.4 Biocon Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Biocon Recent Developments/Updates
        7.4.6 Biocon Competitive Strengths & Weaknesses
    7.5 Celltrion
        7.5.1 Celltrion Details
        7.5.2 Celltrion Major Business
        7.5.3 Celltrion Erythropoietin Stimulating Agents Product and Services
        7.5.4 Celltrion Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Celltrion Recent Developments/Updates
        7.5.6 Celltrion Competitive Strengths & Weaknesses
    7.6 Roche
        7.6.1 Roche Details
        7.6.2 Roche Major Business
        7.6.3 Roche Erythropoietin Stimulating Agents Product and Services
        7.6.4 Roche Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Roche Recent Developments/Updates
        7.6.6 Roche Competitive Strengths & Weaknesses
    7.7 Intas Pharmaceuticals
        7.7.1 Intas Pharmaceuticals Details
        7.7.2 Intas Pharmaceuticals Major Business
        7.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Product and Services
        7.7.4 Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Intas Pharmaceuticals Recent Developments/Updates
        7.7.6 Intas Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Johnson and Johnson
        7.8.1 Johnson and Johnson Details
        7.8.2 Johnson and Johnson Major Business
        7.8.3 Johnson and Johnson Erythropoietin Stimulating Agents Product and Services
        7.8.4 Johnson and Johnson Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Johnson and Johnson Recent Developments/Updates
        7.8.6 Johnson and Johnson Competitive Strengths & Weaknesses
    7.9 Teva Pharmaceutical Industries
        7.9.1 Teva Pharmaceutical Industries Details
        7.9.2 Teva Pharmaceutical Industries Major Business
        7.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product and Services
        7.9.4 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
        7.9.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
    7.10 Thermo Fisher Scientific
        7.10.1 Thermo Fisher Scientific Details
        7.10.2 Thermo Fisher Scientific Major Business
        7.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Product and Services
        7.10.4 Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Thermo Fisher Scientific Recent Developments/Updates
        7.10.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Erythropoietin Stimulating Agents Industry Chain
    8.2 Erythropoietin Stimulating Agents Upstream Analysis
    8.3 Erythropoietin Stimulating Agents Midstream Analysis
    8.4 Erythropoietin Stimulating Agents Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Erythropoietin Stimulating Agents Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Erythropoietin Stimulating Agents Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Erythropoietin Stimulating Agents Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Erythropoietin Stimulating Agents Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Erythropoietin Stimulating Agents Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Erythropoietin Stimulating Agents Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Erythropoietin Stimulating Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Erythropoietin Stimulating Agents Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Erythropoietin Stimulating Agents Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Erythropoietin Stimulating Agents Players in 2022
    Table 12. World Erythropoietin Stimulating Agents Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Erythropoietin Stimulating Agents Company Evaluation Quadrant
    Table 14. Head Office of Key Erythropoietin Stimulating Agents Player
    Table 15. Erythropoietin Stimulating Agents Market: Company Product Type Footprint
    Table 16. Erythropoietin Stimulating Agents Market: Company Product Application Footprint
    Table 17. Erythropoietin Stimulating Agents Mergers & Acquisitions Activity
    Table 18. United States VS China Erythropoietin Stimulating Agents Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Erythropoietin Stimulating Agents Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Erythropoietin Stimulating Agents Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Erythropoietin Stimulating Agents Revenue Market Share (2018-2023)
    Table 23. China Based Erythropoietin Stimulating Agents Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Erythropoietin Stimulating Agents Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Erythropoietin Stimulating Agents Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Erythropoietin Stimulating Agents Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Erythropoietin Stimulating Agents Revenue Market Share (2018-2023)
    Table 29. World Erythropoietin Stimulating Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Erythropoietin Stimulating Agents Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Erythropoietin Stimulating Agents Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Erythropoietin Stimulating Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Erythropoietin Stimulating Agents Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Erythropoietin Stimulating Agents Market Size by Application (2024-2029) & (USD Million)
    Table 35. Pfizer Basic Information, Area Served and Competitors
    Table 36. Pfizer Major Business
    Table 37. Pfizer Erythropoietin Stimulating Agents Product and Services
    Table 38. Pfizer Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Pfizer Recent Developments/Updates
    Table 40. Pfizer Competitive Strengths & Weaknesses
    Table 41. Amgen Basic Information, Area Served and Competitors
    Table 42. Amgen Major Business
    Table 43. Amgen Erythropoietin Stimulating Agents Product and Services
    Table 44. Amgen Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Amgen Recent Developments/Updates
    Table 46. Amgen Competitive Strengths & Weaknesses
    Table 47. BioSidus Basic Information, Area Served and Competitors
    Table 48. BioSidus Major Business
    Table 49. BioSidus Erythropoietin Stimulating Agents Product and Services
    Table 50. BioSidus Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. BioSidus Recent Developments/Updates
    Table 52. BioSidus Competitive Strengths & Weaknesses
    Table 53. Biocon Basic Information, Area Served and Competitors
    Table 54. Biocon Major Business
    Table 55. Biocon Erythropoietin Stimulating Agents Product and Services
    Table 56. Biocon Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Biocon Recent Developments/Updates
    Table 58. Biocon Competitive Strengths & Weaknesses
    Table 59. Celltrion Basic Information, Area Served and Competitors
    Table 60. Celltrion Major Business
    Table 61. Celltrion Erythropoietin Stimulating Agents Product and Services
    Table 62. Celltrion Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Celltrion Recent Developments/Updates
    Table 64. Celltrion Competitive Strengths & Weaknesses
    Table 65. Roche Basic Information, Area Served and Competitors
    Table 66. Roche Major Business
    Table 67. Roche Erythropoietin Stimulating Agents Product and Services
    Table 68. Roche Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Roche Recent Developments/Updates
    Table 70. Roche Competitive Strengths & Weaknesses
    Table 71. Intas Pharmaceuticals Basic Information, Area Served and Competitors
    Table 72. Intas Pharmaceuticals Major Business
    Table 73. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product and Services
    Table 74. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Intas Pharmaceuticals Recent Developments/Updates
    Table 76. Intas Pharmaceuticals Competitive Strengths & Weaknesses
    Table 77. Johnson and Johnson Basic Information, Area Served and Competitors
    Table 78. Johnson and Johnson Major Business
    Table 79. Johnson and Johnson Erythropoietin Stimulating Agents Product and Services
    Table 80. Johnson and Johnson Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Johnson and Johnson Recent Developments/Updates
    Table 82. Johnson and Johnson Competitive Strengths & Weaknesses
    Table 83. Teva Pharmaceutical Industries Basic Information, Area Served and Competitors
    Table 84. Teva Pharmaceutical Industries Major Business
    Table 85. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product and Services
    Table 86. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Teva Pharmaceutical Industries Recent Developments/Updates
    Table 88. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 89. Thermo Fisher Scientific Major Business
    Table 90. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product and Services
    Table 91. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Erythropoietin Stimulating Agents Upstream (Raw Materials)
    Table 93. Erythropoietin Stimulating Agents Typical Customers
List of Figure
    Figure 1. Erythropoietin Stimulating Agents Picture
    Figure 2. World Erythropoietin Stimulating Agents Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Erythropoietin Stimulating Agents Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Erythropoietin Stimulating Agents Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Erythropoietin Stimulating Agents Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Erythropoietin Stimulating Agents Revenue (2018-2029) & (USD Million)
    Figure 13. Erythropoietin Stimulating Agents Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Erythropoietin Stimulating Agents Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Erythropoietin Stimulating Agents Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Erythropoietin Stimulating Agents by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Erythropoietin Stimulating Agents Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Erythropoietin Stimulating Agents Markets in 2022
    Figure 27. United States VS China: Erythropoietin Stimulating Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Erythropoietin Stimulating Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Erythropoietin Stimulating Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Erythropoietin Stimulating Agents Market Size Market Share by Type in 2022
    Figure 31. Epoetin Alfa
    Figure 32. Epoetin Beta
    Figure 33. Darbepoetin Alfa
    Figure 34. Others
    Figure 35. World Erythropoietin Stimulating Agents Market Size Market Share by Type (2018-2029)
    Figure 36. World Erythropoietin Stimulating Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Erythropoietin Stimulating Agents Market Size Market Share by Application in 2022
    Figure 38. Hospitals
    Figure 39. Clinics
    Figure 40. Others
    Figure 41. Erythropoietin Stimulating Agents Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Erythropoietin Stimulating Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Erythropoietin Stimulating Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 09 Jan 2023

date Medical Care

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

Global Erythropoietin Stimulating Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Erythropoietin Stimulating Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Erythropoietin Stimulating Agents market size was valued at USD 9197.8 million in 2023 and is forecast to a readjusted size of USD 12120 million by 2030 with a CAGR of 4.0% during review period.

Product Tags

Erythropoietin Stimulating Agents

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>